Tuberculosis Surveillance Report in Japan - Insights and Trends
Explore the latest tuberculosis surveillance report from Japan for the year 2018, highlighting key statistics, trends, and insights. Learn about pulmonary and extra-pulmonary tuberculosis cases, resistance rates, and comparisons with other countries like the Philippines, China, Vietnam, and Nepal.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
TUBERCULOSIS IN JAPAN Annual Report - 2018 T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
PTB = pulmonary tuberculosis, EPTB = extra-pulmonary tuberculosis Clin = clinically confirmed, bac = bacteriologically confirmed T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
PHL= the Philippines, CHN= China, VNM= Vietnam, NPL= Nepal T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
Number Proportion T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA Bar = number, line = proportion, RR = rifampicin resistance, MDR = multi-drug resistance J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA Bar = number, line = proportion, INH = isoniazid J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
Number Proportion T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
